» Articles » PMID: 32450906

Impact of Sex and Gender on COVID-19 Outcomes in Europe

Overview
Journal Biol Sex Differ
Publisher Biomed Central
Specialties Biology
Physiology
Date 2020 May 27
PMID 32450906
Citations 603
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Emerging evidence from China suggests that coronavirus disease 2019 (COVID-19) is deadlier for infected men than women with a 2.8% fatality rate being reported in Chinese men versus 1.7% in women. Further, sex-disaggregated data for COVID-19 in several European countries show a similar number of cases between the sexes, but more severe outcomes in aged men. Case fatality is highest in men with pre-existing cardiovascular conditions. The mechanisms accounting for the reduced case fatality rate in women are currently unclear but may offer potential to develop novel risk stratification tools and therapeutic options for women and men.

Content: The present review summarizes latest clinical and epidemiological evidence for gender and sex differences in COVID-19 from Europe and China. We discuss potential sex-specific mechanisms modulating the course of disease, such as hormone-regulated expression of genes encoding for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) entry receptors angiotensin converting enzyme (ACE) 2 receptor and TMPRSS2 as well as sex hormone-driven innate and adaptive immune responses and immunoaging. Finally, we elucidate the impact of gender-specific lifestyle, health behavior, psychological stress, and socioeconomic conditions on COVID-19 and discuss sex specific aspects of antiviral therapies.

Conclusion: The sex and gender disparities observed in COVID-19 vulnerability emphasize the need to better understand the impact of sex and gender on incidence and case fatality of the disease and to tailor treatment according to sex and gender. The ongoing and planned prophylactic and therapeutic treatment studies must include prospective sex- and gender-sensitive analyses.

Citing Articles

Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines.

Liu Z, Cai L, Xing M, Qiao N, Liu J, Li X Biosaf Health. 2025; 6(3):153-164.

PMID: 40078728 PMC: 11894967. DOI: 10.1016/j.bsheal.2024.04.001.


Sex differences research is important!.

Becker J, Ahmed S Biol Sex Differ. 2025; 16(1):20.

PMID: 40065326 PMC: 11892286. DOI: 10.1186/s13293-025-00702-x.


The relationship of age, sex and prothrombin time related to the severity and mortality of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis.

Mirza A, Halim C, Sari M F1000Res. 2025; 11:729.

PMID: 40061909 PMC: 11889402. DOI: 10.12688/f1000research.107398.3.


Biochemical differences based on sex and clusters of biomarkers in patients with COVID-19: analysis from the CARDIO COVID 19-20 registry.

Canon-Estrada F, Munoz-Ordonez J, Escalante-Forero M, Rodas Y, Arteaga-Tobar A, Azcarate-Rodriguez V BMC Cardiovasc Disord. 2025; 25(1):147.

PMID: 40045210 PMC: 11881352. DOI: 10.1186/s12872-025-04565-3.


Identifying and Validating Prognostic Hyper-Inflammatory and Hypo-Inflammatory COVID-19 Clinical Phenotypes Using Machine Learning Methods.

Ji X, Guo Y, Tang L, Gao C J Inflamm Res. 2025; 18:3009-3024.

PMID: 40034687 PMC: 11874972. DOI: 10.2147/JIR.S504028.


References
1.
Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R . Sex and gender differences in myocardial hypertrophy and heart failure. Circ J. 2010; 74(7):1265-73. DOI: 10.1253/circj.cj-10-0196. View

2.
Straus S, Corey L, Burke R, Savarese B, Barnum G, Krause P . Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet. 1994; 343(8911):1460-3. DOI: 10.1016/s0140-6736(94)92581-x. View

3.
Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S . Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020; 382(17):1653-1659. PMC: 7121452. DOI: 10.1056/NEJMsr2005760. View

4.
Yang J, Lin S, Ji X, Guo L . Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2009; 47(3):193-9. PMC: 7088164. DOI: 10.1007/s00592-009-0109-4. View

5.
Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J, Turner A . Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020; 126(10):1456-1474. PMC: 7188049. DOI: 10.1161/CIRCRESAHA.120.317015. View